Axim Biotechnologies Inc (OTCQB:AXIM)

0.43
Delayed Data
As of Dec 13
 +0.025 / +6.17%
Today’s Change
0.36
Today|||52-Week Range
2.50
-42.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-10.1M-5.8M-4.2M-6.8M
 
 
 
 
 
Depreciation1.1K3.4K3.4K3.4K
 
 
 
 
 
Total Other Cash Flow8.4M4.2M846.3K2.1M
 
 
 
 
 
Funds From Operations-1.7M-1.6M-3.3M-4.6M
 
 
 
 
 
Funds From/For Other Operating Expenses-144.6K-289.8K-244.2K218.8K
 
 
 
 
 
Net Cash Flow - Operating Activities-1.5M-1.3M-3.1M-4.8M
 
 
 
 
 
 
InvestingCapital Expenditures-16.8K0.000.000.00
 
 
Net Cash Flow Investing-16.8K0.000.000.00
 
 
 
FinancingShort Term Borrowings-31.1K14.00-171.00370.00
 
 
 
 
 
Long Term Borrowings--1.4M3.9M1.8M
 
 
 
 
Long Term Debt Reduction---124.8K-13.5K-2.0M
 
 
 
 
Net Proceeds Stock Sale20.0K115.0K0.004.4M
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing1.0M533.2K500.0K407.5K
 
 
 
 
 
Other Uses - Financing0.00--0.00----
Net Cash Flow - Financing997.9K1.9M4.4M4.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-527.0K579.2K1.4M-252.2K